norstella-logo-white
News

How robust data technology is transforming the design and execution of viable clinical trials

While incorporating real-world data (RWD) and real-world evidence (RWE) across the drug development lifecycle is getting a lot of attention, the application of such insights gleaned from rigorous analysis to the design and execution of clinical trials has yet to be widely adopted, despite its potential to address some of these persistent challenges.

A paradigm shift that leverages advanced tech-enabled data analytics can aid pharmaceutical companies in overcoming common clinical trial delays related to randomization and a host of other trial design and execution issues, such as trial eligibility criteria, predicted responses, estimated sample size, endpoint selection, and increased diversity.

Read More

Work with us

Join our mission

We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.

Work with us
work-with-us-img
get-in-touch-img

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?

We want to hear from you